Amgen (AMGN) Tops Q4 EPS by 11c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. NVDA
2. PCVX
3. PTC
4. MSFT
5. SPY
6. META
7. GMAB
8. GOOGL
9. AMD
10. BBIO

Go back to Amgen (AMGN) Tops Q4 EPS by 11c

Amgen (AMGN) Announces Sumission of Kyprolis sNDA to FDA, MAA to EMA

January 27, 2015 4:35 PM EST

Amgen (NASDAQ: AMGN) and its subsidiary Onyx Pharmaceuticals, Inc., announced the submission of a supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) and a Marketing Authorization Application (MAA) to the European Medicines Agency (EMA) for Kyprolis (carfilzomib) for Injection to seek approval for the treatment of patients with relapsed multiple myeloma who have received at least... More